Drug-related gingival hyperplasia

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Drug-related gingival hyperplasia

Drug-related gingival hyperplasia is a cutaneous condition characterized by enlargement of the gums noted during the first year of drug treatment.[1] Although the mechanism of drug related gingival hyperplasia is not well understood, some risk factors for the condition include the duration of drug use and poor oral hygiene.[2] In most cases, alternative drugs are given, in order to avoid this side effect.[3]

See also[edit]


  1. ^ Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 978-1-4160-2999-1.
  2. ^ Mohan, RP; Rastogi, K; Bhushan, R; Verma, S (23 April 2013). "Phenytoin-induced gingival enlargement: a dental awakening for patients with epilepsy". BMJ Case Reports. 2013: bcr2013008679. doi:10.1136/bcr-2013-008679. PMC 3645126. PMID 23616318.
  3. ^ Srivastava, AmitKumar; Kundu, Debabrata; Bandyopadhyay, Prasanta; Pal, AsitKumar (2010). "Management of amlodipine-induced gingival enlargement: Series of three cases". Journal of Indian Society of Periodontology. 14 (4): 279–81. doi:10.4103/0972-124X.76931. PMC 3118083. PMID 21731258.